Analyze of Risk Factors Affecting the Outcomes of Docetaxel-prednisone Combination in the Treatment of Metastatic Castration-resistant Prostate Cancer
Burak Arslan, Mehmet Fatih Akbulut, Özkan Onuk, Aydın İsmet Hazar, Arif Özkan, Cem Tuğrul Gezmiş, Buğra Çetin & Memduh Aydın · Journal of Advances in Medicine and Medical Research · 2016
Objective: To analyze potential factors affecting the outcomes of docetaxel and prednisone (DP) combination therapy in patients with castration resistant prostate cancer (CRPC). Methods: A total of 272 patients were treated with DP chemotherapy for CRPC between April 2006 and Jan...
Open access
Research Article
10.9734/BJMMR/2016/25855